SMTL ID : 4bgh.1

Crystal Structure of CDK2 in complex with pan-CDK Inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x 3I6: 4-((5-BROMO-4-(PROP-2-YN-1-YLAMINO)PYRIMIDIN-2-YL)AMINO)BENZENESULFONAMIDE(Non-covalent)

3I6.1: 16 residues within 4Å: Chain A: I.10, V.18, A.31, V.64, F.80, E.81, F.82, L.83, H.84, Q.85, D.86, K.89, Q.131, N.132, L.134, D.145 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.18, A:D.86, A:L.134 Hydrogen bonds: A:L.83, A:L.83, A:D.86, A:D.86, A:K.89, A:D.145 Water bridges: A:Q.85

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lucking, U. et al., The Lab Oddity Prevails: Discovery of Pan-Cdk Inhibitor (R)- S-Cyclopropyl-S-(4-{[4-{[(1R,2R)-2-Hydroxy-1-Methylpropyl]Oxy}-5-(Trifluoromethyl)Pyrimidin-2-Yl]Amino}Phenyl)Sulfoximide (Bay 1000394) for the Treatment of Cancer. Chemmedchem (2013)

Release Date

2013-09-04

Peptides

CYCLIN-DEPENDENT KINASE 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CYCLIN-DEPENDENT KINASE 2

Related Entries With Identical Sequence